Details view | IP Australia | Trade Mark Search

Additional fields:
Address History and Publication details Endorsements as at 10 November 2018 Opposition details

Trade mark 2696232

Words	WE NUKE CANCER
Image
Image description
Status	published: Under examination
Priority date	12 Mar 2026 (Convention)
Classes	5, 42
Kind	Word

Dates
Acceptance due	16 Dec 2027
First report	16 Sep 2026
Filing	14 Sep 2026

Owner	Address for service
Actinium Pharmaceuticals, Inc. 100 Park Avenue, 23rd Floor New York, NEW YORK, 10017 UNITED STATES OF AMERICA	Dentons Australia Limited Level 43, Bourke Place 600 Bourke Street MELBOURNE, VIC, 3000 AUSTRALIA

Goods & Services

Class 5: Medicinal preparations for use in oncology; pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; radiopharmaceutical preparations for the treatment of cancer

Class 42: Scientific research and development; Pharmaceutical research and development; Research and development of antibodies; Research and development of medicines; Research and development of new products; Research and development of conjugated antibodies; Research and development in the field of pharmaceuticals; Research and development of advanced learning technologies and teaching methods; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer

Convention details
Date	12 Mar 2026
Number	99698638
Country	UNITED STATES OF AMERICA

Indexing constituents

Word

NUKE

CANCER

Image

Australian Trade Mark Search

Trade mark 2696232

Goods & Services

Indexing constituents